Status:
COMPLETED
Border Region Area Lifestyle Intervention Study for Healthy Neurocognitive Ageing Diabetes
Lead Sponsor:
Queen's University, Belfast
Collaborating Sponsors:
Western Health and Social Care Trust
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The objective is to evaluate a culturally tailored adaptation of The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) protocol targeted for individuals with...
Detailed Description
Dementia is the most frequent neurodegenerative condition and poses a major health burden with high socioeconomic costs. Attempts to find pharmacologic treatments have been largely unsuccessful, promp...
Eligibility Criteria
Inclusion
- Patients with Type 2 Diabetes mellitus
- aged ≥50 years
- within five years of diagnosis
- access to a computer, tablet or smartphone -
Exclusion
- conditions affecting safe engagement in the intervention (especially the exercise component)
- insulin therapy
- malignant diseases
- major depression within 6 months
- dementia/substantial cognitive decline
- Mini Mental State Examination \<20
- symptomatic cardiovascular disease
- revascularization within 1 year
- severe loss of vision, hearing, or communicative ability
- conditions preventing cooperation as judged by the study physician
- coincident participation in any intervention trial. -
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT05304975
Start Date
November 1 2021
End Date
August 31 2023
Last Update
February 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South West Acute Hospital
Enniskillen, Co Fermanagh, United Kingdom